BTIG raised the firm’s price target on Establishment Labs to $53 from $45 and keeps a Buy rating on the shares after its smaller than expected Q4 loss. End-markets and distributor ordering patterns now appear to be stabilizing, with the company’s global market checks indicating continued improvements throughout 2024, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ESTA:
- Is ESTA a Buy, Before Earnings?
- Establishment Labs Amends Credit Terms with Oaktree Fund
- Establishment Labs Announces Potential 2M Share Sale
- Establishment Labs launches Motiva Implants in China
- Establishment Labs to sell 2M shares at $25.00 in private placement
Questions or Comments about the article? Write to editor@tipranks.com